Skip to main content

Aristotle Atlantic Partners, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1697267 SARASOTA, FL

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$16,759,538
-$645,405 QoQ
Shares Held
37,532
-2.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
18 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Aristotle Atlantic Partners, LLC holds $53,023,615 across 5 Biotechnology names. VRTX ranks #2 (31.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 VRTX
Vertex Pharmaceuticals Inc / Ma
This page
37,532 $16,759,538

All Filings in VRTX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $16,759,538 37,532
2025-12-31 $17,404,943 38,391
2025-09-30 $15,588,838 39,804
2025-06-30 $20,201,395 45,376
2025-03-31 $23,264,572 47,986
2024-12-31 $20,638,777 51,251
2024-09-30 $25,158,036 54,094
2024-06-30 $24,648,109 52,586
2024-03-31 $24,546,382 58,722
2023-12-31 $11,224,873 27,587
2023-09-30 $3,224,940 9,274
2023-06-30 $3,393,116 9,642
2023-03-31 $548,851 1,742
2022-12-31 $499,300 1,729
2022-09-30 $502,930 1,737
2022-06-30 $416,767 1,479
2022-03-31 $240,353 921
2021-06-30 $12,409,923 61,548